Organosilane for Surface Cleaning in Intensive Care Units
NCT ID: NCT05673226
Last Updated: 2025-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10301 participants
INTERVENTIONAL
2023-11-06
2025-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units
NCT07233837
Daily Chlorexidine Bath for Health Care Associated Infection Prevention
NCT05485051
4% Chlorhexidine Gluconate Daily Bathing for Prevention of Hospital-acquired Infections in Intensive Care Settings
NCT03639363
Effectiveness of Chlorhexidine Wipe for Prevention of Multidrug-resistant Organisms in Intensive Care Unit Patients
NCT01989416
An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD
NCT02269800
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surface disinfection with organosilane
Organosilane will be sprayed on the surfaces, using an atomizer. When the environment has been completely covered (i.e., when all surfaces and equipment have a slightly damp film), we will proceed with the second phase of the disinfection of all heavily touched surfaces. surfaces of the bed, with a microfiber cloth with organosilane.
Surface disinfection with Organosilane
Organosilane will be sprayed on the surfaces, using an atomizer. When the environment has been completely covered (i.e., when all surfaces and equipment have a slightly damp film), we will proceed with the second phase of the disinfection of all heavily touched surfaces. surfaces of the bed, with a microfiber cloth with organosilane.
Usual surface disinfection
The control group will perform standard cleaning and disinfection of the beds and the environment according to their previous protocols, using the usual products.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surface disinfection with Organosilane
Organosilane will be sprayed on the surfaces, using an atomizer. When the environment has been completely covered (i.e., when all surfaces and equipment have a slightly damp film), we will proceed with the second phase of the disinfection of all heavily touched surfaces. surfaces of the bed, with a microfiber cloth with organosilane.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* ICUs that may use any organosilane formulation for surface disinfection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Sirio-Libanes
OTHER
Hospital Moinhos de Vento
OTHER
Hospital Alemão Oswaldo Cruz
OTHER
Hospital do Coracao
OTHER
Beneficência Portuguesa de São Paulo
OTHER
Hospital Israelita Albert Einstein
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Jean Bittar
Belém, , Brazil
Santa Casa de Misericórdia
Belo Horizonte, , Brazil
Hospital de Base do Distrito Federal
Brasília, , Brazil
Hospital Universitário de Brasília
Brasília, , Brazil
Hospital Otoclínica
Fortaleza, , Brazil
Hospital Geral de Goiânia
Goiânia, , Brazil
Hospital do Tricentenário
Olinda, , Brazil
Hospital Escola Universidade Federal de Pelotas
Pelotas, , Brazil
Hospital Ernesto Dornelles
Porto Alegre, , Brazil
Hospital Ana Nery
Salvador, , Brazil
Hospital Santa Cruz
Santa Cruz do Sul, , Brazil
Hospital Presidente Vargas
São Luís, , Brazil
A.C. Camargo Cancer Center
São Paulo, , Brazil
Hospital do Coração
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
52639521.1.1001.0071
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.